Kyverna Therapeutics, Inc.
KYTX
10 insider filings · Latest: May 27, 2026
Common Stock Transactions
No transactions found.
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | May 29 4:30 PM | Ian T ClarkDirector | Grant/Award | 20,582 | $8.59 | 20,582(D) | View → |
| May 27, 2026 | May 29 4:30 PM | Fred E CohenDirector | Grant/Award | 20,582 | $8.59 | 20,582(D) | View → |
| May 27, 2026 | May 29 4:30 PM | Beth C SeidenbergDirector | Grant/Award | 20,582 | $8.59 | 20,582(D) | View → |
| May 27, 2026 | May 29 4:30 PM | Mert AktarDirector | Grant/Award | 20,582 | $8.59 | 20,582(D) | View → |
| May 18, 2026 | May 20 4:30 PM | Gregory S. MartiniChief Financial Officer | Grant/Award | 325,000 | $8.54 | 325,000(D) | View → |
| May 4, 2026 | May 6 4:30 PM | Nadia DacChief Commercial Officer | Grant/Award | 300,000 | $9.00 | 300,000(D) | View → |
| Mar 13, 2026 | Mar 17 4:30 PM | Marc GrassoChief Financial Officer | Grant/Award | 65,000 | $8.95 | 65,000(D) | View → |
| Mar 13, 2026 | Mar 17 4:30 PM | Warner Weston BiddleDirector, Chief Executive Officer | Grant/Award | 350,000 | $8.95 | 350,000(D) | View → |
| Mar 13, 2026 | Mar 17 4:30 PM | Naji GehchanExhibit 24 - Power of Attorney Chief Medical & Development Officer | Grant/Award | 105,000 | $8.95 | 105,000(D) | View → |